213 related articles for article (PubMed ID: 31776278)
21. Priming with DNA Expressing Trimeric HIV V1V2 Alters the Immune Hierarchy Favoring the Development of V2-Specific Antibodies in Rhesus Macaques.
Devasundaram S; Rosati M; Valentin A; Weiss S; Itri V; Trinh HV; Bear J; Chowdhury B; LaBranche CC; Montefiori D; Ferrari G; Rao M; Kong XP; Zolla-Pazner S; Pavlakis GN; Felber BK
J Virol; 2020 Dec; 95(2):. PubMed ID: 33087466
[TBL] [Abstract][Full Text] [Related]
22. Polyfunctional Fc Dependent Activity of Antibodies to Native Trimeric Envelope in HIV Elite Controllers.
Kant S; Zhang N; Barbé A; Routy JP; Tremblay C; Thomas R; Szabo J; Côté P; Trottier B; LeBlanc R; Rouleau D; Harris M; Dupuy FP; Bernard NF
Front Immunol; 2020; 11():583820. PubMed ID: 33101312
[TBL] [Abstract][Full Text] [Related]
23. Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses.
Prévost J; Zoubchenok D; Richard J; Veillette M; Pacheco B; Coutu M; Brassard N; Parsons MS; Ruxrungtham K; Bunupuradah T; Tovanabutra S; Hwang KK; Moody MA; Haynes BF; Bonsignori M; Sodroski J; Kaufmann DE; Shaw GM; Chenine AL; Finzi A
J Virol; 2017 Apr; 91(7):. PubMed ID: 28100618
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
[TBL] [Abstract][Full Text] [Related]
25. Selection of HIV Envelope Strains for Standardized Assessments of Vaccine-Elicited Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies.
Mielke D; Stanfield-Oakley S; Borate B; Fisher LH; Faircloth K; Tuyishime M; Greene K; Gao H; Williamson C; Morris L; Ochsenbauer C; Tomaras G; Haynes BF; Montefiori D; Pollara J; deCamp AC; Ferrari G
J Virol; 2022 Jan; 96(2):e0164321. PubMed ID: 34730393
[TBL] [Abstract][Full Text] [Related]
26. Combined HIV-1 Envelope Systemic and Mucosal Immunization of Lactating Rhesus Monkeys Induces a Robust Immunoglobulin A Isotype B Cell Response in Breast Milk.
Nelson CS; Pollara J; Kunz EL; Jeffries TL; Duffy R; Beck C; Stamper L; Wang M; Shen X; Pickup DJ; Staats HF; Hudgens MG; Kepler TB; Montefiori DC; Moody MA; Tomaras GD; Liao HX; Haynes BF; Ferrari G; Fouda GGA; Permar SR
J Virol; 2016 May; 90(10):4951-4965. PubMed ID: 26937027
[TBL] [Abstract][Full Text] [Related]
27. Induction of Heterologous Tier 2 HIV-1-Neutralizing and Cross-Reactive V1/V2-Specific Antibodies in Rabbits by Prime-Boost Immunization.
Townsley S; Mohamed Z; Guo W; McKenna J; Cleveland B; LaBranche C; Beaumont D; Shen X; Yates NL; Pinter A; Tomaras GD; Ferrari G; Montefiori DC; Hu SL
J Virol; 2016 Oct; 90(19):8644-60. PubMed ID: 27440894
[TBL] [Abstract][Full Text] [Related]
28. Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial.
Gottardo R; Bailer RT; Korber BT; Gnanakaran S; Phillips J; Shen X; Tomaras GD; Turk E; Imholte G; Eckler L; Wenschuh H; Zerweck J; Greene K; Gao H; Berman PW; Francis D; Sinangil F; Lee C; Nitayaphan S; Rerks-Ngarm S; Kaewkungwal J; Pitisuttithum P; Tartaglia J; Robb ML; Michael NL; Kim JH; Zolla-Pazner S; Haynes BF; Mascola JR; Self S; Gilbert P; Montefiori DC
PLoS One; 2013; 8(9):e75665. PubMed ID: 24086607
[TBL] [Abstract][Full Text] [Related]
29. Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa.
Gray GE; Huang Y; Grunenberg N; Laher F; Roux S; Andersen-Nissen E; De Rosa SC; Flach B; Randhawa AK; Jensen R; Swann EM; Bekker LG; Innes C; Lazarus E; Morris L; Mkhize NN; Ferrari G; Montefiori DC; Shen X; Sawant S; Yates N; Hural J; Isaacs A; Phogat S; DiazGranados CA; Lee C; Sinangil F; Michael NL; Robb ML; Kublin JG; Gilbert PB; McElrath MJ; Tomaras GD; Corey L
Sci Transl Med; 2019 Sep; 11(510):. PubMed ID: 31534016
[TBL] [Abstract][Full Text] [Related]
30. HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineages.
Moody MA; Yates NL; Amos JD; Drinker MS; Eudailey JA; Gurley TC; Marshall DJ; Whitesides JF; Chen X; Foulger A; Yu JS; Zhang R; Meyerhoff RR; Parks R; Scull JC; Wang L; Vandergrift NA; Pickeral J; Pollara J; Kelsoe G; Alam SM; Ferrari G; Montefiori DC; Voss G; Liao HX; Tomaras GD; Haynes BF
J Virol; 2012 Jul; 86(14):7496-507. PubMed ID: 22553329
[TBL] [Abstract][Full Text] [Related]
31. Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.
Zolla-Pazner S; Powell R; Yahyaei S; Williams C; Jiang X; Li W; Lu S; Wang S; Upadhyay C; Hioe CE; Totrov M; Kong X
J Virol; 2016 Dec; 90(24):10993-11006. PubMed ID: 27630234
[TBL] [Abstract][Full Text] [Related]
32. Modulation of Antibody Responses to the V1V2 and V3 Regions of HIV-1 Envelope by Immune Complex Vaccines.
Hioe CE; Kumar R; Upadhyay C; Jan M; Fox A; Itri V; Peachman KK; Rao M; Liu L; Lo NC; Tuen M; Jiang X; Kong XP; Zolla-Pazner S
Front Immunol; 2018; 9():2441. PubMed ID: 30416503
[TBL] [Abstract][Full Text] [Related]
33. RV144 HIV-1 vaccination impacts post-infection antibody responses.
Mdluli T; Jian N; Slike B; Paquin-Proulx D; Donofrio G; Alrubayyi A; Gift S; Grande R; Bryson M; Lee A; Dussupt V; Mendez-Riveria L; Sanders-Buell E; Chenine AL; Tran U; Li Y; Brown E; Edlefsen PT; O'Connell R; Gilbert P; Nitayaphan S; Pitisuttihum P; Rerks-Ngarm S; Robb ML; Gramzinski R; Alter G; Tovanabutra S; Georgiev IS; Ackerman ME; Polonis VR; Vasan S; Michael NL; Kim JH; Eller MA; Krebs SJ; Rolland M
PLoS Pathog; 2020 Dec; 16(12):e1009101. PubMed ID: 33290394
[TBL] [Abstract][Full Text] [Related]
34. Co-receptor Binding Site Antibodies Enable CD4-Mimetics to Expose Conserved Anti-cluster A ADCC Epitopes on HIV-1 Envelope Glycoproteins.
Richard J; Pacheco B; Gohain N; Veillette M; Ding S; Alsahafi N; Tolbert WD; Prévost J; Chapleau JP; Coutu M; Jia M; Brassard N; Park J; Courter JR; Melillo B; Martin L; Tremblay C; Hahn BH; Kaufmann DE; Wu X; Smith AB; Sodroski J; Pazgier M; Finzi A
EBioMedicine; 2016 Oct; 12():208-218. PubMed ID: 27633463
[TBL] [Abstract][Full Text] [Related]
35. Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG.
Tomaras GD; Ferrari G; Shen X; Alam SM; Liao HX; Pollara J; Bonsignori M; Moody MA; Fong Y; Chen X; Poling B; Nicholson CO; Zhang R; Lu X; Parks R; Kaewkungwal J; Nitayaphan S; Pitisuttithum P; Rerks-Ngarm S; Gilbert PB; Kim JH; Michael NL; Montefiori DC; Haynes BF
Proc Natl Acad Sci U S A; 2013 May; 110(22):9019-24. PubMed ID: 23661056
[TBL] [Abstract][Full Text] [Related]
36. Envelope-Specific Recognition Patterns of HIV Vaccine-Induced IgG Antibodies Are Linked to Immunogen Structure and Sequence.
Nadai Y; Held K; Joseph S; Ahmed MIM; Hoffmann VS; Peterhoff D; Missanga M; Bauer A; Joachim A; Reimer U; Zerweck J; McCormack S; Cope AV; Tatoud R; Shattock RJ; Robb ML; Sandstroem EG; Hoelscher M; Maboko L; Bakari M; Kroidl A; Wagner R; Weber J; Pollakis G; Geldmacher C
Front Immunol; 2019; 10():717. PubMed ID: 31105688
[No Abstract] [Full Text] [Related]
37. The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals.
Veillette M; Coutu M; Richard J; Batraville LA; Dagher O; Bernard N; Tremblay C; Kaufmann DE; Roger M; Finzi A
J Virol; 2015 Jan; 89(1):545-51. PubMed ID: 25339767
[TBL] [Abstract][Full Text] [Related]
38. Epitope specificity of human immunodeficiency virus-1 antibody dependent cellular cytotoxicity [ADCC] responses.
Pollara J; Bonsignori M; Moody MA; Pazgier M; Haynes BF; Ferrari G
Curr HIV Res; 2013 Jul; 11(5):378-87. PubMed ID: 24191939
[TBL] [Abstract][Full Text] [Related]
39. The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope.
de Souza MS; Ratto-Kim S; Chuenarom W; Schuetz A; Chantakulkij S; Nuntapinit B; Valencia-Micolta A; Thelian D; Nitayaphan S; Pitisuttithum P; Paris RM; Kaewkungwal J; Michael NL; Rerks-Ngarm S; Mathieson B; Marovich M; Currier JR; Kim JH;
J Immunol; 2012 May; 188(10):5166-76. PubMed ID: 22529301
[TBL] [Abstract][Full Text] [Related]
40. The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120.
Karasavvas N; Billings E; Rao M; Williams C; Zolla-Pazner S; Bailer RT; Koup RA; Madnote S; Arworn D; Shen X; Tomaras GD; Currier JR; Jiang M; Magaret C; Andrews C; Gottardo R; Gilbert P; Cardozo TJ; Rerks-Ngarm S; Nitayaphan S; Pitisuttithum P; Kaewkungwal J; Paris R; Greene K; Gao H; Gurunathan S; Tartaglia J; Sinangil F; Korber BT; Montefiori DC; Mascola JR; Robb ML; Haynes BF; Ngauy V; Michael NL; Kim JH; de Souza MS;
AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1444-57. PubMed ID: 23035746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]